ClinConnect ClinConnect Logo
Search / Trial NCT05564871

Effectiveness of Occupational Therapy Teleintervention in Pediatric

Launched by HEBREW UNIVERSITY OF JERUSALEM · Sep 29, 2022

Trial Information

Current as of November 13, 2025

Not yet recruiting

Keywords

Telemedicine, Ndd's, Occupational Therapy

ClinConnect Summary

This clinical trial is studying the effectiveness of a new way to provide occupational therapy for children aged 5-8 years who have neurodevelopmental disorders (NDDs). These conditions can make it hard for kids to participate in everyday activities. Because many families in Israel struggle to access traditional therapy services, this study is exploring the use of teleintervention, which means therapy sessions conducted over video calls. The trial aims to see if this remote approach can help children achieve their personal goals and improve their quality of life.

To participate, children must speak Hebrew at a native level and be able to identify at least three specific challenges they face in daily life. Families should have access to a computer with a webcam and an iPad connected to the internet. The study will involve 40 children, with half receiving therapy online and half receiving in-person sessions. Participants can expect 12 weekly sessions where they will work on their goals with the support of occupational therapists. The researchers will assess how well the teleintervention works compared to traditional methods and gather feedback from families to improve future services.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Hebrew at mother tongue level
  • Child's ability to identify at least three functional difficulties for the purpose of setting treatment goals
  • Availability of computer with web camera and an IPad connected to broadband or Wi-Fi in their home
  • Exclusion Criteria:
  • Children with somatic or physical disabilities, children diagnosed with ASD, following a brain injury or children with mental health disorders.

About Hebrew University Of Jerusalem

The Hebrew University of Jerusalem, a leading academic institution in Israel, is renowned for its cutting-edge research and innovation in various fields, including medicine and life sciences. With a commitment to advancing healthcare, the university actively sponsors clinical trials that aim to explore novel therapeutic interventions and improve patient outcomes. Leveraging its multidisciplinary expertise and state-of-the-art facilities, the Hebrew University fosters collaboration among researchers, clinicians, and industry partners to translate scientific discoveries into practical applications, thereby enhancing the quality of care and contributing to the global medical community.

Locations

Patients applied

0 patients applied

Trial Officials

Yafit Gilboa, PhD

Study Director

Hebrew University of Jerusalem

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials